Southeast Asia is entering a new investment cycle, but Thailand stands out due to a highly orchestrated, state-led industrial transformation. Many professionals still view regional expansion merely as a pursuit of cheap labor, but the reality of the Thailand 4.0 investment 2026 landscape demands a different approach. This initiative is not just economic branding; it […]

Covered Areas >

Vietnam

Indonesia

Thailand

Socials

What We Offer >

Services

Audit and Assurance Global Company Registration Branding and Digital Agency Market Readiness Assistance Linguistics

Accounting Firms and Tax Service IT Advisory Human Resource Management Trade and Procurement Consulting Legal

Supports

FAQ Terms of Service Privacy Policy

Socials

VIETTONKIN CONSULTING

Blog Articles

M&A in Indonesia’s Pharmaceutical Sector: A Guide for Strategic Buyers

By David Lang on November 26, 2025

The call came at 7 PM on a Friday. Our client’s multi-million-dollar acquisition in Indonesia, a key part of their strategy for continued growth, was at risk of collapse. The target company’s licenses weren’t as secure as they appeared, a detail missed by their previous advisors. From handling hundreds of legal challenges in the pharma […]

Navigating Foreign Pharma Investment Opportunities in Indonesia’s Health Sector

By David Lang on November 26, 2025

Three months into a planned pharma investment in Indonesia, we hit an unexpected roadblock. A Fortune 500 client’s legal team was panicking because the regulatory approval process had stalled, threatening their entire market entry timeline. The reality in Southeast Asian markets is that the official process and the practical requirements are often two different things. […]

Securing Market Success: Best Practices for Managing Drug and Supplement Quality in Vietnam

By Long Nguyen on November 25, 2025

Vietnam’s markets for pharmaceuticals and dietary supplements are expanding rapidly, attracting significant investment focused on health and wellness. However, this growth comes with substantial quality-related risks. For investors, a lapse in product quality is not just a compliance issue; it’s a direct threat to financial performance, market reputation, and consumer safety. Understanding the distinct responsibilities […]

Pharma Policy Frameworks Shaping Global Drug Regulation in 2025

By David Lang on November 25, 2025

During my cooperation with UNICEF, I learned something crucial that has shaped how I approach every Fortune 500 consultation: government pharma policy is not just a set of rules; it's a statement of national strategy. With global pharmaceutical supply chains shifting, countries like Indonesia are using pharmaceutical policies as a powerful tool to attract manufacturing, […]

Tighter Vietnam Pharmacy Practice Requirements: Overcoming Challenges, Seizing Opportunities

By David Lang on November 24, 2025

Recent shifts in Vietnam's regulatory landscape signal a deliberate move towards international standards in pharmacy practice, presenting both a complex challenge and a significant opportunity for any pharmaceutical business establishment. As of 2025, the government is tightening the management of pharmaceutical business, with Circular 31/2025/TT-BYT, guided by the Ministry of Health, emerging as the cornerstone […]

Indonesia’s Pharmaceutical Industry Uncovered: A Strategic Guide for Investors

By David Lang on November 24, 2025

The labyrinthine nature of Indonesian regulations often presents a deceptively straightforward facade, a lesson hard-learned through extensive on-the-ground experience. A client, a major player in the global pharmaceutical industry, was ready to enter one of the most promising emerging markets, but the paper trail didn't match the reality on the ground. From our work on […]

« Previous 1 2 3 4 5 6 … 89 Next »

Blog Articles

Market Entry

M&A in Indonesia’s Pharmaceutical Sector: A Guide for Strategic Buyers

by David Lang on November 26, 2025

FDI & Investment

Navigating Foreign Pharma Investment Opportunities in Indonesia’s Health Sector

by David Lang on November 26, 2025

Legal & Compliance

Securing Market Success: Best Practices for Managing Drug and Supplement Quality in Vietnam

by Long Nguyen on November 25, 2025

Market Entry

Pharma Policy Frameworks Shaping Global Drug Regulation in 2025

by David Lang on November 25, 2025

FDI, Market Entry

Tighter Vietnam Pharmacy Practice Requirements: Overcoming Challenges, Seizing Opportunities

by David Lang on November 24, 2025

FDI & Investment

Indonesia’s Pharmaceutical Industry Uncovered: A Strategic Guide for Investors

by David Lang on November 24, 2025

« Previous 1 2 3 4 5 6 … 89 Next »

About Us

Founded in 2009, Viettonkin Consulting is a multi-disciplinary group of consulting firms headquartered in Hanoi, Vietnam with offices in Ho Chi Minh City, Jakarta, Bangkok, Singapore, and Hong Kong and a strong presence through strategic alliances throughout Southeast Asia. Our firm’s guiding mission is aimed towards facilitating intra-ASEAN investments and connecting investors in Southeast Asia with the rest of the world, thus promoting international business relationships and strengthening inter-nation connections.

Contact

Email:

info@viettonkin.com.vn

Phone Number:

+84 977093166

Company

About Us Countries Capabilities Insights Contact Us

Support

FAQ

Other

Subscribe to our insights to look at the critical issue that your business is facing and stay ahead of the competition in a rapidly changing world.